Synonyms for hyperandrogenic or Related words with hyperandrogenic

andropause              comorbid              hypoestrogenism              pcos              rheumatological              hypothyroid              menoxenia              oligomenorrhea              prostatism              hyperandrogenism              hyperandrogenemia              oligoovulation              hyperthyroid              cushings              hypereninemic              underactive              lypodystrophy              arthropathic              prionrelated              treatedcancer              hsdd              hypercortisolism              ohss              hypogonadism              hyperphosphatemic              rheumatologic              asthenic              hyperinsulinism              gynecomastia              dysosteogenesis              hypergonadotropic              hyperprolactinemia              dysautonomic              siteconditionshlgt              tissuedisorderspain              oligomenorrhoea              hypopigmentary              hypopituitary              asthenospermia              eclampsia              hypertrichosis              keutel              lipidemia              hypogonadotropic              obesitas              climacteric              dyslipogenesis              virilization              sundowning              andromorphous             



Examples of "hyperandrogenic"
Because hyperandrogenism can appear as a symptom of numerous different genetic and medical conditions, it is difficult to make a general statement on whether hyperandrogenic symptoms can be passed from parent to offspring. However, a collection of the conditions with hyperandrogenic symptoms, including polycystic ovary syndrome, have been observed as hereditary in certain cases. One potential cause of polycystic ovary syndrome is maternal hyperandrogenism, where the hormonal irregularities of the mother can affect the development of the child during gestation, resulting in the passing of polycystic ovary syndrome from mother to child.
Following her sixth-place finish in the 800 metres at the 2016 Summer Olympics, Sharp was reported to have said that "it was difficult to compete against Caster Semenya and other hyperandrogenic athletes after the rule to suppress testosterone levels was overturned." Sharp was also criticised in the media when she appeared to ignore Semenya post-race, while embracing fellow runners Joanna Jóźwik and Melissa Bishop. Sharp has since defended her comments, saying on Twitter that: Sharp had previously claimed that "there were obvious athletes with heightened testosterone" and that there were "two separate races being run."
Symptoms generally considered hyperandrogenic can also manifest as results of consuming certain drugs. This can happen according to one of five major mechanisms, namely the direct introduction of androgens to the body, the binding of the drug to androgen receptors and subsequent participation in androgenic action (as is the case with anabolic-androgenic steroids), the reduction of sex hormone-binding globulin plasma concentration that leads to a resulting increase in free testosterone, the interference with and alteration of the hypothalamic–pituitary–ovarian (HPO) axis, or the increase in release of adrenal androgens.
Her biographer Max Dohle concludes that Foekje, having a Y-chromosome, would never have been allowed to race in the last 45 years. The Barr body test (1966) as well as the test based on PCR (1992) scan for a Y-chromosome or an SRY-gene on the Y-chromosome. All female athletes with a Y-chromosome were expelled from competition from 1966 until 2011. At the end of the century, renowned institutions worldwide protested against the viewpoint of the International Olympic Committee, causing the mandatory gender test based on the Y chromosome to be abandoned. In case of doubt an athlete with a Hyperandrogenic Syndromes can still be tested, by a multidisciplinary medical team, during a large tournament like The Olympic Games. The IAAF and the IOC test on testosterone levels since May 2011. An athlete with hyperandrogenism not having CAIS will not be allowed to compete without a suitable medical treatment.
In 1979, Dr. New described a form of mild steroid 21-hydroxylase deficiency called nonclassical 21-hydroxylase deficiency, which is characterized by diverse hyperandrogenic symptoms appearing postnatally in males and females. The remarkable prevalence of 1 in 27 Ashkenazi Jews of a mild form of CAH was documented by Dr. New in 1985 and the genetic frequency of the mutation is 1 in 3 in the Ashkenazi Jewish population. These studies established nonclassical 21-hydroxylase deficiency as the most frequent disorder of all autosomal recessive diseases in humans. While a spectrum of severity of congenital adrenal hyperplasia had always been observed, Dr. New was first to identify the mild form with specific molecular mutations.